2024 Annual Meeting | C117 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Date Tuesday 04/16/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ronald C. Petersen, MD, PhD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the construct of mild cognitive impairment, identify criteria for the diagnosis of MCI, use MCI as a clinical syndrome, differentiate underlying causes of MCI for treatment, develop a program for evaluating patients for pharmacotherapy, and evaluate the longitudinal outcome of patients with MCI.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT	Speaker	Mild Cognitive Impairment: Overview Ronald C. Petersen, MD, PhD, FAAN
01:30 PM - 02:00 PM MDT	Speaker	Atypical Presentations of MCI Oscar L. Lopez, MD, FAAN
02:00 PM - 02:30 PM MDT	Speaker	Treatment of MCI David J. Gill, MD, FAAN
02:30 PM - 03:00 PM MDT	Speaker	Case Discussion Ronald C. Petersen, MD, PhD, FAAN, Oscar L. Lopez, MD, FAAN, David J. Gill, MD, FAAN

Faculty Disclosures
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
David J. Gill, MD, FAAN	Dr. Gill has nothing to disclose.

��ɫ��

��ɫ��